Osang Healthcare Co.,Ltd (036220.KQ) stock: key figures, P/E, revenue and dividend
Health Care · South Korea
Osang Healthcare Co.,Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 80.49 bn KRW | 128.63 bn KRW |
| Gross profit | 25.57 bn KRW | 57.14 bn KRW |
| Operating income | -24.80 bn KRW | 2.43 bn KRW |
| EBIT | -23.03 bn KRW | 3.64 bn KRW |
| Net income | -11.36 bn KRW | 3.11 bn KRW |
| Diluted EPS – continuing operations | -828.82 KRW | 226.09 KRW |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Osang Healthcare Co.,Ltd
Osang Healthcare Co.,Ltd researches, develops, and sells various diagnostic biosensors in South Korea and internationally. The company offers diagnostic biosensors for blood glucose, hemoglobin A1c, cholesterol, immuno diagnosis, molecular diagnosis, and others. It also exports its products to approximately 110 countries worldwide. The company was formerly known as Infopia Co., Ltd. and changed its name to Osang Healthcare Co.,Ltd in April 2017. Osang Healthcare Co.,Ltd was founded in 1996 and is headquartered in Anyang-si, South Korea.
More stocks
- Marathon Bancorp, Inc. /MD/ (MBBC)
- Laredo Oil, Inc. (LRDC)
- Grove Collaborative Holdings, Inc. (GROV)
- NEUROPHET, Inc. (380550.KQ)
- Cj Seafood (011150.KS)
- SAGA COMMUNICATIONS INC (SGA)
- Sugentech Inc (253840.KQ)
- IMPACT BIOMEDICAL INC. (IBO)
- READING INTERNATIONAL INC (RDI)
- Sinsin Pharmaceutical Co. Ltd (002800.KQ)
- Semi Total Solution Inc. (0017J0.KQ)
- Noble Development Public Company Limited (NOBLE.BK)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.